Anthrax targets

Aug 20, 2012

A trawl of the genome of the deadly bacterium Bacillus anthracis has revealed a clutch of targets for new drugs to combat an epidemic of anthrax or a biological weapons attack. The targets are all proteins that are found in the bacteria but not in humans and are involved in diverse bacterial processes such as metabolism, cell wall synthesis and bacterial persistence. The discovery of a range of targets might bode well for creating a drug cocktail that could preclude the emergence of drug resistance.

Ravi Gutlapalli of the Department of Biotechnology, at Acharya Nagarjuna University in Guntur, Andhra Pradesh, India, and colleagues there and at Osmanaia University College for Women in Hyderabad, suggest that the search for drugs to fight is of increasing importance as we face an ongoing threat of its use as a biological weapon. The team has now carried out a search of the and identified 270 non-redundant, non-human homologous genes and 103 essential genes of the bacteria as possible .

The team explains that they have fished out sixteen membrane-bound proteins, seven proteases and three that are all novel from their trawl any one of which might now be used in the rational design of new drugs with previously unused modes of action. This latter point is most important in reducing the chances of the bacteria quickly evolving resistance.

Early diagnosis and treatment with potent antibiotics is essential in any of the three clinical forms of anthrax: cutaneous, gastrointestinal and pulmonary. Unfortunately, the bacteria have evolved resistance to common antibiotics including ciprofloxacin, doxycycline and beta-lactam type drugs. The team now hopes that its identification of a range of novel targets for antibiotics will allow medicinal chemists to quickly screen for activity among diverse molecules as putative antibiotics.

With several possible targets in hand, researchers now need to create homology models of each against which potential drugs might be screened on the computer and thence synthesize in the laboratory and tested against the bacteria under secure conditions.

Explore further: How a molecular Superman protects the genome from damage

More information: "Genome wide search for identification of potential drug targets in Bacillus anthracis" in Int. J. Computational Biology and Drug Design, 2012, 5, 164-179

add to favorites email to friend print save as pdf

Related Stories

New medical weapons to protect against anthrax attacks

Jun 23, 2010

The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any ...

Researchers develop novel method to find new antibiotics

Nov 20, 2006

Bacteria are a cunning foe; at a worrisome rate, they are developing resistance to the current arsenal of antibiotic drugs. Without new drugs, society may be approaching a world reminiscent of the pre-antibiotic era, when ...

Recommended for you

Cell architecture: Finding common ground

Oct 16, 2014

When it comes to cellular architecture, function follows form. Plant cells contain a dynamic cytoskeleton which is responsible for directing cell growth, development, movement, and division. So over time, changes in the cytoskeleton ...

Scientists identify "naïve-like" human stem cell

Oct 16, 2014

Scientists from our university and Berlin have identified a type of human stem cell that appears to be "naïve-like" – able to develop into any type of cell. The discovery of this cell type could potentially ...

Shaping the way to see the world

Oct 16, 2014

The proliferation of cells, in particular the orientation in which they divide, is key in regulating the shapes of tissues. However, the cellular mechanisms that govern cell proliferation and cell division orientation are ...

User comments : 0